Sep 24, 2026 07:17PM
Aug 26, 2026 06:44AM
Aug 25, 2026 07:05AM
Aug 25, 2026 07:05AM
Aug 24, 2026 07:05AM
Aug 24, 2026 07:05AM
Aug 10, 2026 06:51AM Regenxbio Inc. (RGNX) PT Lowered to $23 at H.C. Wainwright
Aug 7, 2026 03:32AM
Aug 7, 2026 03:32AM
Aug 6, 2026 07:05AM
Jul 20, 2026 03:19AM
Jul 18, 2026 02:55PM
Jun 29, 2026 07:05AM
Jun 29, 2026 07:05AM REGENXBIO Announces First Patient Dosed in Phase IIb/III NAAVIGATE Trial of Surabgene Lomparvovec in Diabetic Retinopathy; Company to Receive $100 Million Milestone
Jun 25, 2026 06:49AM
Jun 24, 2026 07:05AM
Jun 24, 2026 07:05AM
Jun 23, 2026 06:51AM
Jun 22, 2026 10:21AM
Jun 22, 2026 09:50AM
Jun 22, 2026 07:31AM FDA aligns with Regenxbio on path to refile MPS II gene therapy BLA
Jun 22, 2026 07:30AM
Jun 22, 2026 06:43AM
Jun 8, 2026 06:54AM
May 14, 2026 07:10AM
May 14, 2026 07:00AM
Mar 17, 2026 09:00AM
Mar 13, 2026 09:00AM RGNX Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in REGENXBIO Inc. Securities Lawsuit — The Gross Law Firm
Mar 12, 2026 05:14AM
Mar 11, 2026 11:51AM
Mar 11, 2026 11:45AM
Mar 10, 2026 09:00AM
Mar 9, 2026 07:46AM
Mar 9, 2026 06:49AM
Mar 6, 2026 04:00PM REGENXBIO Inc. Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm Before April 14, 2026 to Discuss Your Rights – RGNX
Mar 5, 2026 02:11PM
Mar 5, 2026 07:05AM
Mar 3, 2026 09:00AM
Feb 27, 2026 01:10AM
Feb 26, 2026 04:00PM
Feb 26, 2026 11:53AM
Feb 24, 2026 09:00AM The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 14, 2026 in REGENXBIO Lawsuit - RGNX
Feb 23, 2026 03:15AM
Feb 20, 2026 04:19AM
Feb 19, 2026 10:15AM
Feb 18, 2026 05:00PM
Feb 16, 2026 10:54AM
Feb 11, 2026 06:40AM
Feb 9, 2026 04:05PM REGENXBIO receives FDA rejection letter for gene therapy RGX-121
Feb 9, 2026 04:05PM

332,016 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All